Biomedicine & Pharmacotherapy Pharmacology
Identification of TAS2R-targeting bioactive compounds against metabolic decline: A novel ex vivo methodology based on enteroendocrine and inflammatory readouts
The publisher did not provide an abstract — full text is available via the link below.